Most people who participate in clinical trials do so for either of the following reasons (or some combination):
1. They will be beneficiaries of good outcomes (treatment will reduce/ eliminate suffering).
2. They are altruists who believe participation will advance science, benefit mankind.
What if it doesn't ? Or what if the results diminish their health or advance their illness? Whether they receive a placebo, too high a dose or insufficient amt of drug... not considering "pain and suffering", who is financially responsible for remediation or therapy after the trial is over? Apparently this is not considered the responsibility of the organization conducting the trial, but rather falls on the shoulders of the participant. Is this true? Is this fair?